Home
EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Market Share Analysis for May 2026

EyePoint Pharmaceuticals, Inc. pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency.

Health > Biotechnology and Pharmaceuticals

Domaineyepointpharma.com

Year Founded1987

Employees51 - 200

Annual Revenue$25M - $50M

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals (including company regionals)

eyepointpharma.com

See more website traffic and engagement information

EyePoint Pharmaceuticals Revenue up to May 2026 is 25M - 50M

revenue generated by EyePoint Pharmaceuticals top domains

EyePoint Pharmaceuticals top domains revenue over 3 years

Revenue for EyePoint Pharmaceuticals top domains

eyepointpharma.com25M - 50M

See more with Sales Intelligence

Total visits to EyePoint Pharmaceuticals's top domains

Understand EyePoint Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

eyepointpharma.com1K

See more with Sales Intelligence

Avg. visit duration in EyePoint Pharmaceuticals's top domains

Analyze EyePoint Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

eyepointpharma.com00:01:37

See more with Sales Intelligence

Avg. pageviews on EyePoint Pharmaceuticals's top domains

See how EyePoint Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

eyepointpharma.com2.91

See more with Sales Intelligence

EyePoint Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by EyePoint Pharmaceuticals

These are the website technologies, by industry, used by EyePoint Pharmaceuticals top domains

Widget (5)

Twemoji

Content Management System (4)

WordPress

Advertising (2)

PubMatic

Email Services (2)

Microsoft Exchange Online

More Technologies

10

See all

News & Signals from EyePoint Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEyePoint Pharmaceuticals, Inc. filed suit against Ocular Therapeutix, Inc. on Mar 20th '26.March 20 (Reuters) - EyePoint filed a lawsuit on Friday accusing rival Ocular Therapeutix of spreading false or misleading information about EyePoint and its lead experimental eye drug.

NewsEyePoint Pharmaceuticals, Inc. launches details for pivotal phase 3 program evaluating vorolanib intravitreal insert.EyePoint Pharmaceuticals has released details for its pivotal phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for the treatment of.

NewsEyePoint Pharmaceuticals, Inc. attended event 2025 RBC Capital Markets Ophthalmology Virtual Conference on Aug 6th '25.WATERTOWN, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) - EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint will participate in a fireside chat at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on Wednesday, August 13, 2025 at 10:00 a.m. ET.